An Intranasal SARS-CoV-2 Vaccine Candidate
Intranasal administration with a single dose of a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine induces potent immune responses.
spike protein
Spikevax Induces Durable Protection from the Delta Variant in Rhesus Macaques
Rhesus macaques that are vaccinated against SARS-CoV-2 are protected from severe disease and probably transmit very little virus when infected with SARS-CoV-2 one year later.
Dynamics of SARS-CoV-2 Vaccine-Induced Antibody Immunity
It is slowly becoming clear that the immunity induced by SARS-CoV-2 vaccination is of overall better quality than that induced by COVID-19.
One and Done
On February 27, 2021, the FDA issued an emergency use authorization for a one-dose SARS-CoV-2 vaccine developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson.
RNA, in a Nutshell
The mRNA vaccine platform is based on decades of previous studies, highlighting the importance of regularly funding basic research.
SARS-CoV-2 UK variant: Does it matter?
A variant of SARS-CoV-2 has been spreading within England, and it has been suggested that this virus is more transmissible. In this video Vincent explains the properties of the SARS-CoV-2 UK variant and why claims that it is more transmissible are not supported by experimental data. This video was recorded on Monday, 21 December 2020. …